Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ · Healthcare
Vertex Pharmaceuticals Incorporated Operating Income 2008–2025
Vertex Pharmaceuticals Incorporated annual/quarterly operating income history and growth rate from 2008 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Vertex Pharmaceuticals Incorporated operating income for the quarter ending March 31, 2026 was 1.1 B, a 80.62% increase year-over-year.
- Vertex Pharmaceuticals Incorporated operating income for the twelve months ending March 31, 2026 was 4.1 B, a 1959.38% decrease year-over-year.
- Vertex Pharmaceuticals Incorporated annual operating income for 2025 was 4.2 B, a 1891.88% decrease from 2024.
- Vertex Pharmaceuticals Incorporated annual operating income for 2024 was -232.9 M, a 106.08% decrease from 2023.
- Vertex Pharmaceuticals Incorporated annual operating income for 2023 was 3.8 B, a 11.04% decrease from 2022.
- Vertex Pharmaceuticals Incorporated annual operating income for 2022 was 4.3 B.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Vertex Pharmaceuticals Inc. Operating Income — FAQ
Vertex Pharmaceuticals Inc. (VRTX) operating income over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is Vertex Pharmaceuticals Inc.'s operating income?
Vertex Pharmaceuticals Inc. (VRTX) reported operating income of $4.17B for fiscal 2025.
Where can I see VRTX's operating income history?
The chart and table above show Vertex Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.